Paper · 2005

Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.

Robert R. Conley, Deanna L. Kelly

PubMed, 42(1), 51–60 · Published 1 January 2005

View at the publisherCite this paper

In brief

“Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.” is a 2005 paper by Robert R. Conley and Deanna L. Kelly, published in PubMed. OpenAlex counts 47 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
47
Most cited in
2020 (6)
Field-weighted impact
1.82
References
53
Authors
2

Abstract

Second-generation antipsychotics (SGAs) are replacing traditional antipsychotics as first line therapy for the treatment of schizophrenia. While recent evidence suggests similar efficacy with low dose conventional antipsychotics, much of the advantage favoring SGAs comes from the fact that there are fewer extrapyramidal side effects (EPS) at effective doses with these drugs. As a medication class… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Conley, R. R., & Kelly, D. L. (2005). Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects. PubMed, 42(1), 51–60. https://pubmed.ncbi.nlm.nih.gov/16134407

MLA 9

Conley, Robert R., and Deanna L. Kelly. “Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.” PubMed, vol. 42, no. 1, 2005, pp. 51–60. https://pubmed.ncbi.nlm.nih.gov/16134407.

Chicago

Conley, Robert R. and Deanna L. Kelly. 2005. “Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.” PubMed 42 (1): 51–60. https://pubmed.ncbi.nlm.nih.gov/16134407.

Harvard

Conley, R. R. and Kelly, D. L. (2005) ‘Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.’, PubMed, 42(1), pp. 51–60. Available at: https://pubmed.ncbi.nlm.nih.gov/16134407.

IEEE

R. R. Conley and D. L. Kelly, “Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.,” PubMed, vol. 42, no. 1, pp. 51–60, 2005.

BibTeX

@article{conley2005second,
  title     = {{Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.}},
  author    = {Conley, Robert R. and Kelly, Deanna L.},
  journal   = {PubMed},
  year      = {2005},
  volume    = {42},
  number    = {1},
  pages     = {51--60},
  url       = {https://pubmed.ncbi.nlm.nih.gov/16134407}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201333
201444
201522
201611
201811
201933
202066
202222
202411
202511

Its field-weighted citation impact is 1.82: it has been cited 1.82 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • atypical antipsychotics
  • schizophrenia
  • clinical pharmacology
  • extrapyramidal symptoms
  • clozapine
  • receptor binding
  • structure-activity relationship
  • adverse drug reactions

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Conley, R. R., & Kelly, D. L. (2005). Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects. PubMed, 42(1), 51–60. https://pubmed.ncbi.nlm.nih.gov/16134407

How many times has this paper been cited?

47 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Robert R. Conley, Deanna L. Kelly.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.